Difference between revisions of "Peripheral nerve sheath tumours"

Jump to navigation Jump to search
Line 111: Line 111:
*No atypia.
*No atypia.
*Mitoses rare/none.
*Mitoses rare/none.
Subtypes:<ref name=pmid10555009>{{cite journal |author=Wang AR, May D, Bourne P, Scott G |title=PGP9.5: a marker for cellular neurothekeoma |journal=Am. J. Surg. Pathol. |volume=23 |issue=11 |pages=1401–7 |year=1999 |month=November |pmid=10555009 |doi= |url=}}</ref>
*Cellular.
*Myxoid.
*Intermediate.


DDx:  
DDx:  
Line 121: Line 126:
===IHC===
===IHC===
Features:<ref name=pmid17325474/>
Features:<ref name=pmid17325474/>
*NKI-C3 +ve.
*NKI/C3 ([[AKA]] NKI-C3) +ve.
*NSE +/-ve.
*NSE +/-ve.
Others:<ref name=pmid17592278>{{cite journal |author=Fetsch JF, Laskin WB, Hallman JR, Lupton GP, Miettinen M |title=Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information |journal=Am. J. Surg. Pathol. |volume=31 |issue=7 |pages=1103–14 |year=2007 |month=July |pmid=17592278 |doi=10.1097/PAS.0b013e31802d96af |url=}}</ref>
*Vimentin +ve.
*CD10 +ve.
*Microphthalmia transcription factor +ve.
*PGP9.5 +ve.


==Malignant peripheral nerve sheath tumours==
==Malignant peripheral nerve sheath tumours==
48,836

edits

Navigation menu